INMD
InMode Ltd. Ordinary Shares
Electromedical & Electrotherapeutic Apparatus
Best Electromedical Stocks 2026 →
InMode Ltd. Ordinary Shares (INMD) Stock: Buy, Sell, or Hold?
$13.62
+0.35 (+2.68%)
▲
5d:
-4.08%
30d:
-4.79%
90d:
-10.39%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (76%)
Quality Score
59/100
Position
SLIGHTLY LOW
30-Day Fair Range
$13.53 – $14.23
Position: SLIGHTLY LOW
Forward P/E & Valuation
9.7x
FAIR
vs 9.6x historical avg
Wall Street Target
$16.17
+21.9% upside
Options IV & Volume
100th pct IV
HIGH volume confirmation
Support / Resistance
$13.07 / $14.54
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: INMD shows positive signals but monitor for confirmation. Market pricing in 0.2% growth. Moderate conviction.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 6, 2026 at $13.35 · last confirmed Nov 6, 2026
Strength: 5.6/10
Get Alerted When INMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.77
Based on 5.0% avg growth
INTRINSIC VALUE TODAY
$10.41
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INMD is currently trading at $13.62, which is considered slightly low relative to its 30-day fair value range of $13.53 to $14.23. The stock's valuation (Forward PE: 9.7) is in line with its historical norms (9.6). At these levels, the market is pricing in 0.2% annual earnings growth.
Technical Outlook: Technically, INMD is in a strong downtrend. Immediate support is located at $13.07, while resistance sits at $14.54.
Market Sentiment: INMD scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $16.17 (+21.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INMD is in a strong downtrend. Immediate support is located at $13.07, while resistance sits at $14.54.
Market Sentiment: INMD scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Implied Volatility is high (100th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $16.17 (+21.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$13.53 -
$14.23
Company Quality Score
59/100
(HOLD)
Options IV Signal
100th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
75.8%
Trading Range & Key Levels
30-Day Trading Range
$13.53 -
$14.23
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$1.85
(13.6%)
Support Level
$13.07
Resistance Level
$14.54
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Options expensive (IV 100th percentile)
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.9% below Wall St target ($16.17)
- BULLISH: Expecting earnings turnaround to 0.2% growth with None% revenue growth
- BULLISH: Bottoming setup score 63/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
9.67
Wall Street Target
$16.17
(+21.9%)
Earnings Growth (YoY)
-31.0%
Profit Margin
20.7%
Valuation Premium vs History
+0.2% premium
PE vs Historical
9.7 vs 9.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.2%
(market-implied from PE analysis)
1-Year Target
$13.29
(+0%)
2-Year Target
$13.32
(+0%)
3-Year Target
$13.34
(+1%)
3-Yr Target (if PE normalizes)
(PE: 10→10)
PE COMPRESSION
$13.25
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 5.9%)
$32.33
(+144%)
Base:
(SPY PE: 9.7, Growth: 5.9%)
$15.74
(+19%)
Bear:
(PE: 8.2, Growth: 5.9%)
$13.38
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 11.17 | Current EPS (TTM): $1.21
Bull Case
$16.85
(+27%)
Analyst growth 13.4%, PE expands to 12.3
Base Case
$15.32
(+16%)
Market implied 13.4%, PE stable at 11.2
Bear Case
$9.19
(-31%)
Severe decline -20.0%, PE contracts to 9.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share INMD Analysis
Share this live INMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INMD)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 16, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits message expresses optimism towards $INMD and $YALA stocks despite ongoing conflicts.
Key Retail Themes:
Company Belief
Conflict Resolution
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 2:17 PM ET
Data refreshes hourly during market hours. Next update: 3:17 PM
Data refreshes hourly during market hours. Next update: 3:17 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 52 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 39 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 45 HOLD |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
16 analysts |
$166 | 46 HOLD |
Advanced INMD Option Strategies
Professional options setups generated by AI based on today's INMD price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INMD Research Pages
